Alzinova AB Total Liabilities

Latest as of March 2026: Skr9.91 Million SEK ≈ $1.07 Million USD

Alzinova AB total liabilities. Based on the latest financial reports, Alzinova AB (ALZ) has total liabilities worth Skr9.91 Million SEK (≈ $1.07 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See ALZ cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Alzinova AB (2012–2025)

Total liabilities of Alzinova AB from 2012 to 2025. This chart illustrates how Alzinova AB's total liabilities have evolved over time, based on quarterly financial data.

Alzinova AB Competitors by Total Liabilities

The table below lists competitors of Alzinova AB ranked by their total liabilities.

Company	Country	Total Liabilities
Kiora Pharmaceuticals Inc NASDAQ:KPRX	USA	$6.92 Million
NGS Group AB (publ) ST:NGS	Sweden	Skr55.14 Million
GLG Corp Ltd AU:GLE	Australia	AU$35.21 Million
TME Pharma N.V. PA:ALTME	France	€3.72 Million
Knightscope Inc NASDAQ:KSCP	USA	$13.49 Million
Close Brothers Group plc LSE:CBG	UK	GBX10.41 Billion
Getty Images Holdings Inc. NYSE:GETY	USA	$2.63 Billion
Mount Burgess Mining NL AU:MTB	Australia	AU$5.17 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Alzinova AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Alzinova AB (ALZ) total assets.

Liquidity & Leverage Metrics

Alzinova AB Total Liabilities Ratios Explained

Alzinova AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alzinova AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alzinova AB (2012–2025)

The table below shows the annual total liabilities of Alzinova AB from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr21.47 Million ≈ $2.31 Million	+128.33%
2024-12-31	Skr9.40 Million ≈ $1.01 Million	+0.77%
2023-12-31	Skr9.33 Million ≈ $1.00 Million	+53.27%
2022-12-31	Skr6.09 Million ≈ $655.15K	+89.09%
2021-12-31	Skr3.22 Million ≈ $346.48K	-32.81%
2020-12-31	Skr4.79 Million ≈ $515.68K	+8.40%
2019-12-31	Skr4.42 Million ≈ $475.71K	+89.33%
2018-12-31	Skr2.33 Million ≈ $251.26K	+0.26%
2017-12-31	Skr2.33 Million ≈ $250.60K	+64.85%
2016-12-31	Skr1.41 Million ≈ $152.02K	-9.79%
2015-12-31	Skr1.57 Million ≈ $168.51K	+165.74%
2014-12-31	Skr589.25K ≈ $63.41K	-19.06%
2013-12-31	Skr728.02K ≈ $78.35K	+328.80%
2012-12-31	Skr169.78K ≈ $18.27K	--

About Alzinova AB

ST:ALZ Sweden Biotechnology

Market Cap

$7.34 Million

Skr68.19 Million SEK

Market Cap Rank

#27666 Global

#601 in Sweden

Share Price

Skr0.34

Change (1 day)

+0.30%

52-Week Range

Skr0.34 - Skr1.92

All Time High

Skr26.90